Ryan Fukushima serves as Chief Operating Officer at Tempus AI Inc. Class A, a leading AI-driven precision medicine company revolutionizing healthcare through data and technology. With more than 15 years of experience in operations, scaling tech-driven enterprises, and strategic leadership, Ryan has been a cornerstone of Tempus since joining in 2016 as Vice President of Operations. His early career included roles at high-growth firms like Groupon, where he honed expertise in operational efficiency, supply chain management, and cross-functional team leadership, earning him a reputation for driving rapid scaling in dynamic environments. Under Ryan's stewardship, Tempus has expanded from a nascent startup to a global powerhouse, processing billions of multimodal data points to accelerate drug discovery and personalized treatments. Key achievements include overseeing the build-out of Tempus' state-of-the-art clinical and molecular labs, which now sequence over 200,000 samples annually; forging strategic partnerships with top pharmaceutical companies like Pfizer and AstraZeneca; and leading the operational infrastructure that supported Tempus' landmark IPO in 2024. His efforts have directly contributed to the company's valuation exceeding $6 billion and its recognition as a top innovator in healthcare AI. In his current role as COO, Ryan oversees all operational facets, including technology infrastructure, laboratory services, global expansion, and enterprise functions, ensuring seamless execution of Tempus' mission to deliver real-world evidence for better patient outcomes. A Chicago native with a degree in Economics from the University of Illinois, Ryan's data-centric approach and operational acumen continue to propel Tempus toward transformative impact in oncology and beyond.